SCHEMBL23965817

SCHEMBL23965817

COCCN(C)c1nc2ccc(N)cc2s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.48
KEAP1 Q14145 1/20 0.44
MAPT P10636 9/20 0.43
ALDH1A1 P00352 4/20 0.43
LMNA P02545 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
KDM4E B2RXH2 3/20 0.42
GLA P06280 3/20 0.42
GAA P10253 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
TMPRSS15 P98073 3/20 0.41
HTT P42858 1/20 0.41
HPGD P15428 3/20 0.40
PKM P14618 2/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21669173 0.88 SMN1; SMN2 (0.49) SMN1; SMN2KEAP1MAPTALDH1A1LMNA
SCHEMBL3752321 0.85 SMN1; SMN2 (0.51) SMN1; SMN2KEAP1MAPTALDH1A1LMNA
SCHEMBL21638287 0.84 SMN1; SMN2 (0.46) SMN1; SMN2KEAP1MAPTALDH1A1LMNA
Hydrochloric Acid SCHEMBL3753726 0.83 SMN1; SMN2 (0.50) SMN1; SMN2KEAP1MAPTALDH1A1MEN1
SCHEMBL4643602 0.82 SMN1; SMN2 (0.49) SMN1; SMN2KEAP1MAPTALDH1A1MEN1
SCHEMBL3744447 0.81 LMNA (0.52) SMN1; SMN2KEAP1MAPTLMNAMEN1
SCHEMBL3748595 0.79 LMNA (0.50) SMN1; SMN2KEAP1MAPTALDH1A1LMNA
SCHEMBL19326467 0.79 MAPT (0.51) SMN1; SMN2KEAP1MAPTALDH1A1LMNA
SCHEMBL3748799 0.78 SMN1; SMN2 (0.44) SMN1; SMN2KEAP1MAPTALDH1A1LMNA
Hydrochloric Acid SCHEMBL3746728 0.78 CYP1A2 (0.51) SMN1; SMN2KEAP1MAPTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same FUJIFILM CORPORATION (JP) 2021-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same HAVCR2, HBS1L, PHKB SMN1; SMN2 4557/4885KEAP1 1858/4885MAPT 2580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.